Keyphrases
Helicobacter Pylori (H. pylori)
100%
Indonesia
87%
Helicobacter Pylori Infection
58%
COVID-19
53%
COVID-19 Patients
43%
Chronic Hepatitis B Patients
40%
Surabaya
38%
Dyspepsia
37%
Fecal Calprotectin
36%
Chronic Liver Disease
31%
Meta-analysis
30%
Diagnostic Value
29%
Atrophic Gastritis
29%
Indonesian
25%
Gastric mucosal
24%
Interleukin-6
24%
Hepatitis B
24%
Liver Cirrhosis
23%
Liver Function
23%
Hepatocellular Carcinoma
23%
Transient Elastography
21%
Chronic Hepatitis
21%
Liver Fibrosis
21%
Pepsinogen
20%
Gastroesophageal Reflux Disease
20%
Lung Tissue
19%
Hepatic Hydrothorax
19%
Core Needle Biopsy
19%
Viral Load
19%
Systematic Meta-analysis
19%
Hepatocellular Carcinoma Patients
19%
Interleukin-6 Expression
19%
Transarterial Chemoembolization
19%
Gastritis
19%
Liver
19%
Fibrosis
18%
Ethnic Groups
18%
General Hospital
17%
Proton Pump Inhibitors
17%
Low Prevalence
17%
Urea Breath Test
17%
Chronic Gastritis
16%
Infection Rate
15%
X Gene mutation
15%
Liver Biopsy
14%
CagA
14%
Infected Patients
14%
Odds Ratio
14%
D-dimer
14%
Hepatitis B Virus X Gene
14%
Medicine and Dentistry
Helicobacter Pylori
84%
COVID-19
68%
Liver Cirrhosis
33%
Stomach Acid
28%
Infection
28%
Helicobacter Infection
22%
Diagnosis
22%
Prevalence
22%
Liver Injury
22%
Atrophic Gastritis
22%
Chronic Liver Disease
21%
Histopathology
21%
Biological Marker
21%
Biopsy Technique
21%
Interleukin 6
19%
Hydrothorax
19%
Transcatheter Arterial Chemoembolization
19%
Faecal Calprotectin
19%
Hepatocellular Carcinoma
19%
Abdominal Cancer
19%
Gastritis
17%
Urea Breath Test
17%
Chronic Hepatitis B
16%
Ethnic Group
16%
Pepsinogen
16%
Bilirubin
15%
Transient Elastography
15%
Proton-Pump Inhibitor
14%
Chronic Gastritis
13%
Cancer
13%
Hepatitis B
13%
Liver Function
13%
Hepatitis B(e) Antigen
13%
Hepatitis B Virus
13%
Hepatitis B Antigen
13%
Carbon 14
11%
Odds Ratio
11%
Pleura Effusion
11%
Cancer Screening
11%
Liver Transplantation
11%
Liver Fibrosis
11%
Liver Biopsy
11%
Digestive System Inflammation
11%
Hypoxemia
11%
Pepsinogen I
10%
Gastroesophageal Reflux
10%
Meta-Analysis
10%
Pylorus
9%
Overall Survival
9%
Patient with Obesity
9%
Pharmacology, Toxicology and Pharmaceutical Science
Helicobacter Pylori
65%
Chronic Hepatitis B
43%
Diseases
42%
Interleukin 6
39%
Calgranulin
39%
Coronavirinae
39%
Hepatitis B Virus
38%
Stomach Acid
34%
Helicobacter Infection
30%
Chronic Liver Disease
29%
Infection
28%
Hepatitis B Antigen
24%
Liver Injury
22%
Fibrosis
21%
Liver Fibrosis
21%
Chronic Hepatitis
21%
Liver Cell Carcinoma
20%
Tumor Necrosis Factor
19%
Prevalence
18%
Hepatitis B(e) Antigen
18%
Gastritis
15%
Hepatitis B
13%
Insulin Resistance
11%
Biological Marker
11%
Proton Pump Inhibitor
11%
Digestive System Inflammation
11%
Inflammation
10%
Gastroesophageal Reflux
10%
Adult Respiratory Distress Syndrome
10%
Metformin
9%
Urease
9%
Telbivudine
9%
Antivirus Agent
9%
Binding Protein
9%
Interleukin 17
9%
Spondylarthritis
9%
Gastrin 17
9%
Colitis
9%
C Reactive Protein
9%
Disease Activity
9%
Interleukin 10
9%
Interleukin 8
9%
Lamivudine
9%
Intestine Injury
9%
Protein P53
9%
Metronidazole
9%
Colorectal Carcinoma
9%
Retrospective Study
9%
Chronic Hepatitis C
8%
Atrophic Gastritis
8%